Log in to save to my catalogue

Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria

Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A726030758

Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria

About this item

Full title

Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria

Publisher

Basel, Switzerland: S. Karger AG

Journal title

International archives of allergy and immunology, 2022-11, Vol.183 (11), p.1198-1208

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Introduction: This study aimed to evaluate factors affecting drug survival and treatment response in patients with chronic urticaria treated with omalizumab in clinical practice. Methods: This study included 386 patients with chronic urticaria. Demographic characteristics, clinical features, laboratory parameters, and omalizumab treatment data were...

Alternative Titles

Full title

Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A726030758

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A726030758

Other Identifiers

ISSN

1018-2438

E-ISSN

1423-0097

DOI

10.1159/000526148

How to access this item